Frontlight ResearchEarly access
Trial site
Southern Adelaide Diabetes & Endocrine Services
- 6running trials
- 9closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes10 trials
- Obesity7 trials
- Type 1 diabetes3 trials
- Chronic kidney disease2 trials
- Coronary artery disease1 trial
- Heart failure1 trial
- Obstructive sleep apnoea1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 314 trials
- Phase 21 trial
- Status
- Completed9 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Eli Lilly and Company8 trials
- Novo Nordisk A/S5 trials
- Boehringer Ingelheim2 trials
Running trials
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Obesity1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026